NRXS SCHEDULE 13D/A: SEC filing
Rosalind Advisors and affiliated reporting persons
Filed with the SEC on · accession 0001622627-26-000033
NRXS filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 16, 2026. Rosalind Advisors and affiliated reporting persons filed an amended Schedule 13D disclosing beneficial ownership of Neuraxis common stock and preferred stock convertible into common stock, subject to a 9.99% blocker.
Summary of the filing
Rosalind Advisors and affiliated reporting persons filed an amended Schedule 13D disclosing beneficial ownership of Neuraxis common stock and preferred stock convertible into common stock, subject to a 9.99% blocker. The filing reflects a passive investment position with no stated plans to influence control of the company.
Key details
✦ Ask GOAX AI about this filing — what it means for NRXS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NRXS?
Click hereFrequently asked questions
What did NRXS file with the SEC on Nov 16, 2026?
NRXS filed a SCHEDULE 13D/A (SEC filing). Rosalind Advisors and affiliated reporting persons filed an amended Schedule 13D disclosing beneficial ownership of Neuraxis common stock and preferred stock convertible into common stock, subject to a 9.99% blocker. The filing reflects a passive investment position with no stated plans to influence control of the company.
How do I read a SCHEDULE 13D/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).
Other NRXS SEC filings
- SCHEDULE 13G/A · SEC filingNov 10, 2026
- 10-Q · SEC filingNov 9, 2026
- 8-K · Dividend changeOct 14, 2026
- 8-K · Executive departureAug 19, 2026
- 10-Q · SEC filingAug 11, 2026
- 424B3 · Secondary offeringAug 6, 2026
- EFFECT · SEC filingAug 3, 2026
- S-3 · Shelf registrationJul 30, 2026
- S-3 · Shelf registrationJul 23, 2026
- 8-K · Dividend changeJul 10, 2026
Get alerts when NRXS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days